¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå
Respiratory Monitoring Devices
»óǰÄÚµå : 1551564
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 295 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

È£Èí ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 73¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù

2023³â¿¡ 46¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â È£Èí ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.9% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 73¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¸Æ¹Ú »ê¼Ò ÃøÁ¤±â´Â CAGR 8.2%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 27¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. »ê¼ÒÆ÷È­µµ ÃøÁ¤±â ºÎ¹®Àº ºÐ¼® ±â°£ µ¿¾È CAGR 6.5%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 12¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 11.2%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ È£Èí ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀåÀº 2023³â 12¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 16¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È 11.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 2.9%¿Í 6.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 4.4%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

È£Èí±â ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ ±¸Á¶¿Í ¹è°æ ±â¼úÀº ¹«¾ùÀΰ¡?

È£Èí ¸ð´ÏÅ͸µ ÀåÄ¡´Â ´Ù¾çÇÑ È£Èí ¸Å°³º¯¼ö¸¦ ÃßÀûÇϴ ÷´Ü ±â¼úÀ» Ȱ¿ëÇÏ¿© ȯÀÚÀÇ È£Èí ±â´ÉÀ» Áö¼ÓÀûÀ¸·Î Æò°¡ÇÏ°í °ü¸®ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â »ê¼ÒÆ÷È­µµ(SpO2), È£Èí¼ö, Á¶¼ö·®, È£±â¸» ÀÌ»êȭź¼Ò(EtCO2)¿Í °°Àº Áß¿äÇÑ ÁöÇ¥¸¦ ÃøÁ¤ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â¸¦ ±¸µ¿ÇÏ´Â ±â¼ú¿¡´Â ¸Æ¹Ú »ê¼Ò ÃøÁ¤±â, Ä«ÇÁ³ë±×·¡ÇÇ, ½ºÆÄÀÌ·Î¸ÞÆ®¸® µîÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¸Æ¹Ú »ê¼Ò ÃøÁ¤±â´Â ºû Èí¼ö ±â¼úÀ» »ç¿ëÇÏ¿© ºñħ½ÀÀûÀ¸·Î Ç÷Áß »ê¼Ò ³óµµ¸¦ ÃøÁ¤Çϰí, Ä«ÇÁ³ë±×·¡ÇǴ ȣ±â Áß ÀÌ»êȭź¼Ò ³óµµ¸¦ ¸ð´ÏÅ͸µÇÏ¿© È£Èí ±â´É¿¡ ´ëÇÑ Áï°¢ÀûÀÎ Çǵå¹éÀ» Á¦°øÇÕ´Ï´Ù. ÆóȰ·®°è´Â Èí±â ¹× È£±â ½Ã °ø±âÀÇ ¾ç°ú À¯·®À» ÃøÁ¤ÇÏ¿© Æó ±â´ÉÀ» Æò°¡ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â¿¡ µðÁöÅÐ ¹× ¹«¼± ±â¼úÀÌ ÅëÇÕµÇ¾î ½Ç½Ã°£ µ¥ÀÌÅÍ ¼öÁý, ¿ø°Ý ¸ð´ÏÅ͸µ, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀÌ °¡´ÉÇØÁ® ±â´ÉÀÌ ´õ¿í Çâ»óµÇ¾ú½À´Ï´Ù. ºÎǰÀÇ ¼ÒÇüÈ­·Î ÀÎÇØ ÈÞ´ë¿ë ¹× Âø¿ëÇü È£Èí ¸ð´ÏÅͰ¡ °³¹ßµÇ¾î ÀÓ»ó ÇöÀå°ú °¡Á¤ ¸ðµÎ¿¡¼­ ´õ¿í Ä£¼÷ÇÏ°í Æí¸®ÇÏ°Ô »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

È£Èí±â ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ ÁÖ¿ä »ç¿ëÀÚ¿Í ±× ¿ä±¸´Â ¹«¾ùÀΰ¡?

È£Èí±â ¸ð´ÏÅ͸µ ÀåÄ¡´Â º´¿ø ³» ÁßÁõ ȯÀÚºÎÅÍ Áý¿¡¼­ ¸¸¼º È£Èí±â ÁúȯÀ» °ü¸®ÇÏ´Â °³Àο¡ À̸£±â±îÁö ´Ù¾çÇÑ »ç¿ëÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ÁßȯÀÚ½Ç(ICU)¿¡¼­ ÀÌ·¯ÇÑ Àåºñ´Â ±â°èÀû ÀΰøÈ£ÈíÀ» ¹Þ°í Àְųª È£Èí°ï¶õÀÌ ½ÉÇÑ È¯ÀÚ¸¦ ¸ð´ÏÅ͸µÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ¸¶Ãë°ú ÀÇ»ç´Â ¼ö¼ú Áß ÀûÀýÇÑ È¯±â¸¦ º¸ÀåÇϰí ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇØ Ä«ÇÁ³ë±×·¡ÇǸ¦ »ç¿ëÇÕ´Ï´Ù. ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), õ½Ä, ¼ö¸é¹«È£ÈíÁõ°ú °°Àº ¸¸¼º È£Èí±â ÁúȯÀº Áõ»óÀ» °ü¸®ÇÏ°í ¾ÇÈ­¸¦ ¿¹¹æÇϱâ À§ÇØ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀÇ À¯º´·üÀº ƯÈ÷ °í·ÉÈ­ »çȸ¿¡¼­ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀüÅëÀûÀÎ ÀÇ·á ȯ°æ ¹Û¿¡¼­ »ç¿ëÇÒ ¼ö Àִ ȣÈí ¸ð´ÏÅ͸µ ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °¡Á¤¿ë È£Èí ¸ð´ÏÅʹ ȯÀÚ¿¡°Ô ÀÚÀ²¼ºÀ» Á¦°øÇϰí, È£Èí±â °Ç°­ »óŸ¦ ÃßÀûÇϰí, ÀÇ·áÁø°ú »óÀÇÇÏ¿© Ä¡·á °èȹÀ» Á¶Á¤ÇÒ ¼ö ÀÖ´Â ÀÚÀ²¼ºÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î È£Èí±â ÇÕº´ÁõÀÇ Á¶±â ¹ß°ß°ú °ü¸®ÀÇ Á߿伺ÀÌ ºÎ°¢µÇ¸é¼­ Á¤È®Çϰí Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÇ Çʿ伺ÀÌ ´õ¿í ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù.

È£Èí ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä Çõ½Å°ú µ¿ÇâÀº ¹«¾ùÀΰ¡?

È£Èí±â ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀº È£Èí±â Ä¡·áÀÇ Àü¸ÁÀ» À籸¼ºÇÏ´Â ±Þ¼ÓÇÑ ¹ßÀü°ú »õ·Î¿î Æ®·»µå¸¦ ¸ñ°ÝÇϰí ÀÖ½À´Ï´Ù. Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» È£Èí ¸ð´ÏÅ͸µ ÀåÄ¡¿¡ ÅëÇÕÇÏ¿© Áø´Ü Á¤È®µµ¸¦ ³ôÀÌ°í ¿¹Ãø ºÐ¼®À» °¡´ÉÇϰÔÇÏ´Â AI ±â¹Ý ½Ã½ºÅÛÀº ¿©·¯ ȯÀÚÀÇ ´ë±Ô¸ð µ¥ÀÌÅÍ ¼¼Æ®¸¦ ºÐ¼®ÇÏ¿© ÆÐÅÏÀ» ½Äº°Çϰí È£Èí±â À̺¥Æ®¸¦ ¹Ì¸® ¿¹ÃøÇÏ¿© ȯÀÚ °á°ú¸¦ °³¼± ÇÒ ¼ö ÀÖ½À´Ï´Ù, ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ÀÇ·áÀÇ ºÎ»óÀº ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ °³¹ßÀ» ÃËÁøÇÏ¿© ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ¸Ö¸® ¶³¾îÁø °÷¿¡¼­ ȯÀÚÀÇ È£Èí »óŸ¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô Çß½À´Ï´Ù. Áö¼ÓÀûÀÎ »ç¿ëÀ» À§ÇØ ¼³°èµÈ ¿þ¾î·¯ºí È£Èí ¸ð´ÏÅÍ´Â ¸¸¼º ÁúȯÀ» ¾Î°í Àִ ȯÀÚ¿Í °æ±â·Â ÃÖÀûÈ­¸¦ ¸ñÇ¥·Î ÇÏ´Â ¿îµ¿¼±¼öµé »çÀÌ¿¡¼­ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â¿¡´Â Á¾Á¾ »ç¿ëÀÚ¿¡°Ô È£Èí±â °Ç°­¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú µ¿ÇâÀ» Á¦°øÇÏ´Â ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ÇÀÌ Å¾ÀçµÇ¾î ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Æ®·»µå´Â »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º¿Í ȯÀÚ Á᫐ ¼³°è¿¡ ÃÊÁ¡À» ¸ÂÃá °ÍÀ¸·Î, °í·ÉÀÇ È¯ÀÚ³ª ±â¼ú ¼÷·Ãµµ°¡ ³·Àº ȯÀÚ µî ´õ ³ÐÀº ¹üÀ§ÀÇ »ç¿ëÀÚ¸¦ À§ÇÑ º¸´Ù Á÷°üÀûÀÎ ±â±â°¡ °³¹ßµÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù.

È®´ëÇϴ ȣÈí °¨½Ã ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

È£Èí±â ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀº ±Þ¼ÓÇÑ È®Àå¿¡ ±â¿©ÇÏ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ¸¸¼º È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡·Î Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¼±Áø±¹ÀÇ °í·ÉÈ­¿Í ÇÔ²² ½ÅÈï±¹ ½ÃÀåÀÇ ¿À¿° ¼öÁذú Èí¿¬À² Áõ°¡´Â COPD, õ½Ä, Æó¾Ï°ú °°Àº Áúº´ÀÇ ¹ßº´·ü Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ƯÈ÷ AI, ¿ø°Ý ÀÇ·á, ¿þ¾î·¯ºí ±â¼ú ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀº È£Èí±â ¸ð´ÏÅ͸µÀ» º¸´Ù Ä£¼÷Çϰí Á¤È®ÇÏ°Ô ¸¸µé°í ´Ù¸¥ ÀÇ·á ½Ã½ºÅÛ°ú ÅëÇÕÇÏ¿© ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖÀ¸¸ç, Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ¿ø°Ý ¸ð´ÏÅ͸µ°ú ÀçÅà ¸ð´ÏÅ͸µÀÇ Çʿ伺ÀÌ ´õ¿í Áß¿äÇØÁö¸é¼­ ÀÌ·¯ÇÑ ±â±âÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âÀÇ Ã¤ÅÃÀ» ´õ¿í °¡¼ÓÈ­½ÃÄ×½À´Ï´Ù. ¶ÇÇÑ, ÀçÅÃÄ¡·á ¹× ÀÚ°¡ °ü¸® ÁöÇâ Áõ°¡¿Í °°Àº ¼ÒºñÀÚ ÇൿÀÇ º¯È­µµ ÈÞ´ë¿ë ¹× »ç¿ëÇϱ⠽¬¿î ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÇコÄɾî ÀÎÇÁ¶ó È®ÃæÀº È£Èí±â °Ç°­ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå Âü¿©Àڵ鿡°Ô »õ·Î¿î ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¸¶Áö¸·À¸·Î, Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀÇ ÃßÁø°ú ±ÔÁ¦ ´ç±¹ÀÇ µðÁöÅÐ Çコ ±â¼ú¿¡ ´ëÇÑ Áö¿øÀ¸·Î È£Èí±â ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¸ð¸àÅÒÀº Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÁÖ¸ñ¹Þ´Â 52°³ ±â¾÷)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Respiratory Monitoring Devices Market to Reach US$7.3 Billion by 2030

The global market for Respiratory Monitoring Devices estimated at US$4.6 Billion in the year 2023, is expected to reach US$7.3 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Pulse Oximeters, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Spirometers segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 11.2% CAGR

The Respiratory Monitoring Devices market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Respiratory Monitoring Devices Market - Key Trends and Drivers Summarized

How Do Respiratory Monitoring Devices Work and What Technologies Are Behind Them?

Respiratory monitoring devices play an essential role in the continuous assessment and management of patients' breathing functions, leveraging advanced technologies to track various respiratory parameters. These devices measure critical metrics such as oxygen saturation (SpO2), respiratory rate, tidal volume, and end-tidal carbon dioxide (EtCO2). The technology driving these devices includes pulse oximetry, capnography, and spirometry. Pulse oximeters, for example, use light absorption techniques to non-invasively determine blood oxygen levels, while capnography monitors the concentration of carbon dioxide in exhaled air, providing immediate feedback on respiratory function. Spirometers assess lung function by measuring the volume and flow of air during inhalation and exhalation. The integration of digital and wireless technologies into these devices has further enhanced their capabilities, allowing for real-time data collection, remote monitoring, and seamless integration with electronic health records (EHRs). The miniaturization of components has enabled the development of portable and wearable respiratory monitors, making these devices more accessible and convenient for both clinical and home settings.

Who Are the Primary Users of Respiratory Monitoring Devices, and What Are Their Needs?

Respiratory monitoring devices cater to a wide range of users, from critical care patients in hospital settings to individuals managing chronic respiratory conditions at home. In intensive care units (ICUs), these devices are indispensable for monitoring patients under mechanical ventilation or those with severe respiratory distress. Anesthesiologists rely on capnography during surgical procedures to ensure proper ventilation and avoid complications. Chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, require ongoing monitoring to manage symptoms and prevent exacerbations. The increasing prevalence of these conditions, particularly in aging populations, has spurred demand for respiratory monitoring devices that can be used outside of traditional healthcare environments. Home-based respiratory monitors provide patients with greater autonomy, enabling them to track their respiratory health and adjust their treatment plans in consultation with healthcare providers. Furthermore, the need for accurate, continuous monitoring has become more pronounced in the wake of the COVID-19 pandemic, which highlighted the importance of early detection and management of respiratory complications.

What Are the Key Innovations and Trends Shaping the Respiratory Monitoring Devices Market?

The respiratory monitoring devices market is witnessing rapid advancements and emerging trends that are reshaping the landscape of respiratory care. One significant trend is the integration of artificial intelligence (AI) and machine learning algorithms into respiratory monitoring devices, enhancing the accuracy of diagnostics and enabling predictive analytics. AI-powered systems can analyze large datasets from multiple patients, identify patterns, and predict respiratory events before they occur, thereby improving patient outcomes. Additionally, the rise of telemedicine has driven the development of remote monitoring solutions, allowing healthcare providers to monitor patients’ respiratory status in real time from distant locations. Wearable respiratory monitors, designed for continuous use, are gaining popularity among patients with chronic conditions and athletes seeking to optimize their performance. These devices often come equipped with mobile applications that provide users with detailed insights and trends about their respiratory health. Another notable trend is the focus on user-friendly interfaces and patient-centered design, which has led to the development of more intuitive devices that cater to a broader audience, including elderly patients and those with limited technological proficiency.

What Are the Growth Drivers Behind the Expanding Respiratory Monitoring Devices Market?

The growth in the respiratory monitoring devices market is driven by several factors that collectively contribute to its rapid expansion. One of the primary drivers is the increasing prevalence of chronic respiratory diseases, which has heightened the demand for continuous monitoring solutions. Aging populations in developed countries, coupled with rising pollution levels and smoking rates in emerging markets, are leading to a higher incidence of conditions such as COPD, asthma, and lung cancer. Technological advancements, particularly in the fields of AI, telemedicine, and wearable technology, have also fueled market growth by making respiratory monitoring more accessible, accurate, and integrated with other healthcare systems. The COVID-19 pandemic further accelerated the adoption of these devices, as the need for remote and home-based monitoring became paramount. Additionally, changing consumer behavior, with a growing preference for home healthcare and self-management, has spurred demand for portable and easy-to-use devices. The expansion of healthcare infrastructure in emerging markets, along with increasing awareness about the importance of respiratory health, has opened up new opportunities for market players. Lastly, the continuous push for innovation, coupled with regulatory support for digital health technologies, is expected to sustain the momentum in the respiratory monitoring devices market for years to come.

Select Competitors (Total 52 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â